real peptides FAQ

Request a certificate of analysis directly from the supplier before purchasing. Any research-grade peptide supplier should provide HPLC purity data, endotoxin testing results, and sterility confirmation for the specific lot being shipped. If the supplier cannot produce a COA or provides only the raw material supplier's certificate without testing the final formulation, that's a red flag for quality control gaps. Real Peptides publishes COAs for every batch on the product page, eliminating the need to request documentation separately.

Request the particle size distribution data and lyophilization protocol documentation. Complete dissolution within 60–90 seconds indicates uniform particle size from controlled lyophilization. Clumping or visible precipitate after 5 minutes signals inconsistent freeze-drying that produces aggregates. Purity measures molecular identity, not physical form; a 99% pure peptide that aggregates during reconstitution is functionally unusable for most assays. Real Peptides provides lyophilization records showing chamber pressure, temperature ramp rates, and primary/secondary drying times because those parameters determine solubility.

Run a Limulus Amebocyte Lysate (LAL) assay on your reconstituted DSIP solution before adding it to cultures. Endotoxin levels above 0.5 EU/mL in culture media trigger NF-κB activation and cytokine release that confound sleep-related signaling research. If LAL testing confirms contamination, the issue is supplier-side. Peptide synthesis without proper endotoxin removal or post-synthesis bacterial contamination. Real Peptides maintains <1 EU/mg in lyophilised form, translating to <0.1 EU/mL in typical reconstituted concentrations. Competitors skipping endotoxin testing cannot guarantee this.

Assume endotoxin contamination until proven otherwise. For in vitro studies, elevated endotoxins activate Toll-like receptor 4 (TLR4) signaling in immune cells and some neuronal populations, confounding neuroendocrine measurements by triggering cytokine release independent of kisspeptin's GnRH-stimulating effect. For in vivo studies, endotoxin-contaminated peptides cause fever, acute-phase protein elevation, and altered hypothalamic-pituitary responsiveness. Variables that invalidate reproductive endpoints. Request LAL assay results before proceeding, or source from a supplier that includes endotoxin testing as standard.

Verify the peptide's certificate of analysis for mass spectrometry confirmation and endotoxin levels. If the COA shows only HPLC data without MS, the peptide may contain sequence errors. A single amino-acid substitution can reduce KISS1R binding affinity by 60% or more, producing weak or absent LH secretion. Request a replacement batch with full MS verification, or switch to a supplier that publishes both metrics by default. Oxidized kisspeptin (detectable as mass shifts of +16 Da for methionine sulfoxide or +32 Da for kynurenine from tryptophan) also loses receptor affinity without appearing impure on standard HPLC.

Contact the supplier immediately and request the COA matching your vial's batch number. If they cannot provide it, you have no verification that your material matches advertised purity. Generic COAs or refusal to provide batch-specific documentation is a quality red flag. Real Peptides publishes COAs on product pages before purchase, allowing verification prior to ordering. Research-grade peptides without traceability introduce uncontrolled variables into experimental design.

Discard the vial immediately and contact the supplier for replacement. Particulate contamination indicates sterility failure or chemical precipitation, both of which invalidate research use. Cloudiness in a reconstituted LIPO-C solution can result from bacterial growth (if stored improperly or if benzyl alcohol concentration is insufficient), protein aggregation (if pH drifted outside 5.5–7.0), or crystallization of choline chloride (if frozen). Real Peptides' formulations undergo sterility testing per USP <71> and are filled under ISO Class 5 laminar flow hoods to prevent particulate introduction, but any breach of the vial seal or temperature excursion above 8°C can compromise sterility.

Request a copy of the LAL assay report for your specific batch lot number. Real Peptides provides this documentation within 24 hours at no additional charge because we test every batch before warehousing. The report shows quantified endotoxin units per milliliter and confirms the result falls below our 0.3 EU/mL acceptance threshold. Competitors who skip endotoxin testing can't produce this documentation because it doesn't exist for their inventory. If your supplier can't provide a dated LAL report tied to your vial's lot number, commission independent testing through a contract laboratory before proceeding with sensitive cell culture protocols. Bacterial endotoxin triggers NF-κB inflammatory pathways that confound neuroprotection studies entirely.

Discard the vial immediately and contact the supplier for replacement. Visible particulates indicate either aggregation during lyophilisation (caused by rapid freeze-drying or high residual moisture) or contamination introduced during filling. Aggregated peptides have reduced bioavailability because receptor binding requires monomeric structure. Aggregates don't dissociate fully in solution. Real Peptides guarantees particle-free reconstitution; if particulates appear, the batch failed quality control and should not have shipped.

Verify that the supplier performs chiral HPLC or optical rotation testing on every batch and specifies L-carnitine purity numerically in the COA. Generic claims like 'pharmaceutical grade' or 'high purity' without quantitative data are insufficient for protocols where stereoisomer contamination affects outcomes. Real Peptides' standard specification is ≥98% L-carnitine, which meets USP monograph requirements. Custom batches with higher purity thresholds can be requested for specialized applications.

The peptide has likely undergone partial degradation. Kisspeptin stored at 4°C for 14 days shows 15–25% loss of bioactivity in cell-based receptor-binding assays, even if HPLC-measured purity appears unchanged. This occurs because oxidation modifies amino-acid side chains without breaking the peptide backbone. The molecule remains intact but pharmacologically compromised. If your experiments allow, run a dose-response comparison between the 4°C-stored batch and a fresh −20°C-stored vial to quantify activity loss. For future orders, reconstitute only the amount needed for immediate use and store the remainder lyophilized at −20°C.

Real Peptides provides complete chain-of-custody documentation including synthesis batch records, third-party analytical certificates, storage temperature logs, and facility cGMP compliance certificates. Competitors operating under research-chemical guidelines often cannot provide this level of documentation because their facilities aren't required to maintain it. For researchers working under FDA IND applications or institutional animal care protocols, the difference between having cGMP documentation and not having it determines whether the study can proceed.

Request batch documentation from your supplier immediately. Legitimate pharmaceutical-grade Cerebrolysin from EVER Neuro Pharma includes a printed lot number on both the vial and outer packaging, linking the product to specific manufacturing dates and quality control testing. If your supplier can't provide a manufacturer's certificate of analysis matching your vial's lot number within 48 hours, you're working with either relabeled product or material from an unverifiable source. Both scenarios indicate quality control failures that compromise experimental validity.

Assume cold-chain integrity was compromised unless proven otherwise. Cerebrolysin's neuropeptides lose 15–25% bioactivity for every 24-hour period spent above 10°C, and visual inspection can't detect this degradation. The solution remains clear even when peptide structure is partially denatured. Contact your supplier for a replacement shipment with documented cold-chain compliance, or commission independent HPLC analysis to verify peptide concentration matches the labeled specification (typically 215.2 mg/mL total peptide content). Real Peptides includes temperature-monitoring stickers on every shipment precisely because peptide stability failures are invisible until experimental results show unexplained variability.

VVerify whether the competitor's purity is guaranteed at time of synthesis or time of shipping. That distinction explains most pricing gaps. A peptide manufactured at 99% purity in February but stored for four months may test at 96–97% by June, while still technically meeting a "≥95% minimum" claim. The lower price reflects older inventory and looser verification standards. Real Peptides maintains higher costs because every batch undergoes independent testing immediately before distribution, and small-batch production prevents the cost savings of bulk manufacturing. The question is whether 2–3% higher purity and verified freshness justifies a 30% price premium. For dose-sensitive work and publishable research, our experience shows it does.

Request one before use, or assume the peptide hasn't been independently verified. In-house testing allows selective reporting. A supplier can run five HPLC analyses and publish only the cleanest chromatogram. Without third-party accountability, there's no way to confirm the peptide matches its label. We recommend purchasing only from suppliers who include accredited lab CoAs as standard. Real Peptides provides them with every order because independent verification protects both the researcher and the supplier.

Switch to a supplier providing batch-specific mass spectrometry confirmation and compare molecular weight data across your recent orders. Batch-to-batch variability in research outcomes often traces to peptide purity fluctuations or sequence errors that HPLC alone cannot detect. If molecular weight varies by more than ±1 Da between batches, you're receiving inconsistent material. Request COAs for the exact batch numbers you've used and verify MS data matches the theoretical mass of DSIP (848.87 Da). Competitors without MS testing cannot diagnose this problem.

Request batch-specific HPLC data for both vials to check for purity variance. Batch-to-batch inconsistency is the clearest signal that a supplier lacks per-batch verification. They're shipping peptides from different synthesis runs without confirming equivalent quality. Real Peptides' small-batch model and per-batch testing eliminate this variable, which is why research institutions requiring multi-month experimental timelines specify suppliers with documented batch consistency.

Stop using it and document the batch number. Particle formation indicates peptide aggregation from degradation or improper synthesis. TB-4 reconstituted correctly in bacteriostatic water should remain clear and colorless for 28 days at 2–8°C. Aggregation suggests the peptide was either synthesized with incomplete deprotection steps, exposed to temperature excursions above 25°C before reconstitution, or contains impurities that catalyze breakdown. This pattern occurs 3–4× more frequently with untested suppliers compared to pharmaceutical-grade sources.

Do not reconstitute or use it. Contact the supplier immediately for replacement. Lyophilized TB-4 should appear as a white to off-white powder with no visible particles, discoloration, or moisture. Cloudiness or yellow tint indicates oxidation, moisture contamination, or bacterial growth during synthesis or storage. Real Peptides replaces any vial showing visual defects before reconstitution at no cost, because these are unambiguous quality failures that no amount of proper handling can correct.